Compared to CML cells, treated with imatinib only, additional stress induction by oligomycin and thapsigargin triggered apoptosis pathways via the activation of caspase 3 and by inhibition of PARP. Here, PARP1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.